ArticleDrug design, development and therapy2020

Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody.

Lei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.